The human gut is populated by an array of bacterial species, which develop important metabolic and immune functions, with a marked effect on the nutritional and health status of the host. Dietary component also play beneficial roles beyond basic nutrition, leading to the development of the functional food concept and nutraceuticals. Therefore, the intestinal microbiota is both a target for nutritional intervention and a factor influencing the biological activity of other food compounds acquired orally. This 20 review focuses on the reciprocal interactions between the gut microbiota and functional food components, and the consequences of these interactions on human health.
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Abstract
The human gut is populated by an array of bacterial species, which develop important metabolic and immune functions, with a marked effect on the nutritional and health status of the host. Dietary component also play beneficial roles beyond basic nutrition, leading to the development of the functional food concept and nutraceuticals. 5 Prebiotics, polyunsaturated fatty acids (PUFAs) and phytochemicals are the most well characterized dietary bioactive compounds. The beneficial effects of prebiotics mainly relay on their influence on the gut microbiota composition and their ability to generate fermentation products (short-chain fatty acids) with diverse biological roles. PUFASs include the ω-3 and ω-6 fatty acids, whose balance may influence diverse aspects of 10 immunity and metabolism. Moreover, interactions between PUFAs and components of the gut microbiota may also influence their biological roles. Phytochemicals are bioactive non-nutrient plant compounds, which have raised interest because of their potential effects as antioxidants, antiestrogenics, anti-inflammatory,
Introduction
The intestinal tract harbours a complex bacterial community (microbiota), integrated by more than 800 different bacterial species, which have an enormous impact on the nutritional and health status of the host. The metabolic activity developed by the gut microbiota contributes to the digestion of dietary compounds, salvage of energy, supply 5 of (micro)nutrients and transformation of xenobiotics. Overall, a balanced gut microbiota composition confers benefits to the host, while microbial imbalances are associated with metabolic and immune-mediated disorders (1, 2) . The composition of the gut microbiota is influenced by endogenous and environmental factors (diet, antibiotic intake, xenobiotics, etc.). Of these factors, the diet is considered a major 10 driver for changes in gut bacterial diversity that may affect its functional relationships with the host (3) . In fact, the microbiome of the adult-type and infant-type microbiota has distinct gene contents to accommodate nutrient acquisition strategies to different diets (4) .
The primary role of diet is providing sufficient nutrients to meet the basic nutritional 15 requirements for maintenance and growth, while giving the consumer a feeling of satisfaction and well-being. In addition, some food components exert beneficial health effects beyond basic nutrition, leading to the concept of functional foods and nutraceuticals (5) . Functional foods are those foods that provide benefits beyond basic nutrition when consumed as part of the regular diet. Nutraceuticals are extracts 20 containing the biologically active food components supplied in other than a food form.
Dietary components with biological effects are susceptible to be metabolized by intestinal bacteria during the gastrointestinal passage, prior being absorbed. The colon has the highest bacterial load and constitutes an active site of metabolism rather than a simple excretion route (6) . The metabolic activity of the gut microbiota on bioactive 25 4 food components can modify the host exposure to these components and their potential health effects. Furthermore, some functional food components influence the growth and/or metabolic activity of the gut microbiota and, thereby, its composition and functions (7, 8) . Therefore, the intestinal microbiota is both a target for nutritional intervention to improving health and a factor influencing the biological activity of other 5 food compounds acquired orally. This review focuses on the reciprocal interactions between the gut microbiota and functional food components, and the consequences of these interactions on human health (Figure 1 ).
Gut microbial ecology 10
The human gut is populated by a vast number of bacterial species (more than 800) that reach the highest concentrations in the colon (up to 10 12 cells per gram of faeces).
The gut colonization process starts immediately after birth and the development and establishment of the infant's microbiota highly depend on environmental factors. The infant's microbiota initially shows low diversity and instability, but evolves into a more 15 stable adult-type microbiota over the first 24 months of life (9). In general, Bifidobacterium populations are dominant in the first months of life, especially in breast-fed infants (up to 90% of the total faecal bacteria) due to the bifidogenic effect of breast milk, while a more-diverse microbiota is found in formula-fed infants, weaning children and adults (10) . Metagenomic analyses show that in adults and weaned 20 children the major constituents of the colonic microbiota are Bacteroides, followed by several genera belonging to the division Firmicutes, such as Eubacterium, Ruminococcus and Clostridium, and the genus Bifidobacterium. By contrast, in infants the genus Bifidobacterium is predominant and also a few genera from the family Enterobacteriaceae, such as Escherichia, Raoultella, and Klebsiella (4). The 25 5 composition of this bacterial ecosystem is dynamic and susceptible to changes driven by dietary factors and diverse disease conditions (11, 12) .
Roles of the gut microbiota in host physiology and health
The gut microbiota develops a number of protective, immune and metabolic 5 functions, which altogether have an enormous impact on the nutritional and health 
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The intestinal microbiota also affects the host metabolism, providing additional enzymes and regulating the expression of genes involved in the utilization of carbohydrates and lipids, and in drugs bioconversion (16) (17) (18) . The number of genes of the collective genome (microbiome) of the microbiota exceeds by far those of the human genome, encoding additional metabolic features (17, 19) . Genomic and 5 physiologic studies have demonstrated that the gut microbiota provides enzymes specialized in the utilization of non-digestible carbohydrates and host-derived glycoconjugates (e.g. mucin), deconjugation and dehydroxylation of bile acids, cholesterol reduction, biosynthesis of vitamins (K and B group) and isoprenoids and metabolism of amino acids and xenobiotics (4, 16, 17) . 10
The microbiome is particularly enriched in genes involved in carbohydrate metabolism and uptake, indicating that complex polysaccharides are the primary energy source for the colonic microbiota (4). The genome sequence of Bifidobacterium longum also has a large number of predicted proteins (more than 8%) related to the catabolism of oligo-and poly-saccharides released from non-digestible plant polymers (20). Some 15 of the most abundant bacterial enzymes involved in the degradation of complex polysaccharides and xenobiotics are β-glycosidases and β-glucuronidases, which may play both beneficial and harmful roles (21) . Glycosidase activities present in the human colonic microbiota act on plant glucosides contributing to nutrient utilization and, in some cases, to the generation of biologically active aglycones with other health benefits 20 (e.g. from isoflavones). The utilization of complex dietary polysaccharides by the microbiota seems to contribute to harvest energy from the diet, which may represent 10% of the daily energy supply (22) . Moreover, the level of exposure to glycosides in the colon, which is dependent on the 20 type of diet consumed, could affect the induction of enzyme activity levels in some members of the gut microbiota and, therefore, influence their functions (21) . Specific glycosidases (xylanases, arabinofuranosidases and xylosidases) required for complete degradation of complex polysaccharides present in plant cell walls, such as arabinans and arabinoxylans, are also encoded by the total faecal microbiota and by strains of the 25 8 main bacterial genera (Bifidobacterium and Bacteroides) (24, 25) . Bifidobacterium longum subsp. infantis ATCC 15697, an isolate from the infant gut, is also equipped with genes and enzymes allowing the preferential consumption of small mass oligosaccharides, which represent 63.9% of the total human milk oligosaccharides available (26, 27) . In addition, genes coding for an endo-alpha-N-5 acetylgalactosaminidase and a 1,2-alpha-L-fucosidase, which hydrolyse high-molecular weight mucin, are present in several Bifidobacterium bifidum strains (28) .
Gut bacterial enzymes are also involved in the metabolism of cholesterol and bile acids. Cholesterol can be reduced to coprostanol by the commensal microbiota, increasing its secretion in faeces. Bile acids are synthesized from cholesterol in the liver 10 mostly as the primary bile acids, cholic acid and chenodeoxycholic acid. Intestinal bacteria are also able to convert these acids into various types of secondary bile acids by catalysing their deconjugation and dehydroxylation, thereby limiting the solubilization and absorption of dietary lipids throughout the intestine (29) . However, these activities can also lead to the generation of secondary bile acids, some of which (deoxycholic acid 15 and lithocholic acid) are considered possible carcinogens. Bacteroides intestinalis and secondarily Bacteroides fragilis and E. coli are potentially involved in the generation of secondary bile acids in the colon (30) .
The metabolic activity of the microbiota can also contribute to the supply of amino acids required by humans. In the presence of fermentable carbohydrate substrates (e.g. 20 non-starch polysaccharides, resistant starch and oligosaccharides), colonic bacteria grow and actively synthesize protein, which can be a soured of amino acids for the host (31) .
Although it is difficult to quantify the protein synthesis and turnover within the large intestine, at lest from 1 to 20% of circulating plasma lysine and threonine in adult human subjects is derived form the intestinal microbiota, as estimated by using labelled 25 9 amino acids (16). Nevertheless, the metabolic activities of the microbiota involved in the degradation of food related nitrogen compounds (e.g. nitrocompounds, sulphurcontaining compounds and amino acids) can lead to the generation of potentially carcinogenetic substances (32) .
The commensal microbiota also regulates the expression of genes involved in the 5 processing and absorption of dietary carbohydrates and complex lipids by the host, which altogether lead to body weight gain and increased fat storage. Gut colonization by commensal bacteria increases the expression of an intestinal monosaccharide transporter and key enzymes (acetyl-CoA carboxylase and fatty acid synthase) of de novo fatty acid biosynthetic pathways (33, 34) . The colonization of germ-free mice also reduces the 10 levels of circulating fasting-induced adipose factor (Fiaf) and the skeletal muscle and liver levels of phosphorylated AMP-activated protein kinase, contributing to fat storage (35) . Furthermore, comparisons between germ-free and colonized rat demonstrated that the intestinal microbiota affect levels of xenobiotic-metabolizing enzymes in large intestine and liver, including glutathione transferases, gastrointestinal glutathione 15 peroxidase, epoxide hydrolases, N-acetyltransferases, and cytochrome P450 activities, which might affect the host ability to detoxify different compounds (36, 37). Therefore, the intestinal tract is inhabited by a complex microbiota that develops strategies to regulate nutrient acquisition and utilization in symbiosis with the host and in response to the diet. The biochemical activity this complex ecosystem generates 20 healthy as well as potentially harmful compounds from the diet and their balance is essential to maintain a healthy status. This could be achieved by diverse nutritional strategies, including the administration of probiotic bacteria and other functional food components, whose roles and interactions with the microbiota are reviewed in the following sections. 25
Prebiotics and gut microbiota
Prebiotics are nondigestible food ingredients, mostly oligosaccharides, which beneficially affect the host by stimulating growth, activity or both of specific intestinal bacteria (38) . The criteria that have to fulfil a prebiotic include, (1) resistance to gastric 5 acidity and mammalian enzymes; (2) susceptibility to be fermented by gut microbiota; and (3) ability to stimulate the growth and/or activity of beneficial intestinal bacteria.
The possible beneficial effects of prebiotics include the control intestinal transit time and bowel habits, and reduction of risk of atherosclerosis, osteoporosis, obesity, type-2 diabetes, cancer, infections and allergies, although their effectiveness in humans is still 10 controversial (38) . The biological effects of prebiotics mainly depend on their influence on the gut microbiota composition and derived metabolites; although some roles could be due to their own structure and direct action (e.g. inhibition of pathogen adhesion by homology with bacterial receptors).
Galacto-oligosaccharides (GOS) and inulin-derivatives (e.g. fructo-oligosaccharides 15
[FOS]) are the prebiotics most commonly commercialized in Europe. GOS are nondigestible oligosaccharides derived from lactose that are found naturally in human milk and consist of chains of galactose monomers. These prebiotics provide beneficial effects in the gastrointestinal tract by stimulating growth of specific members of the intestinal microbiota (e.g. bifidobacteria). GOS alone or combined with FOS are mainly added to 20 infant formula to promote the prevalence of a microbiota composition similar to that resulting from breast-feeding during both milk-feeding and the weaning period. This dietary strategy may increase the total amount of faecal bifidobacteria and favour a Bifidobacterium species composition resembling that of breast-fed infants (39, 40) . The gut microbiota has proved to be essential for the production of active isoflavone metabolites with oestrogen-like activity; additionally, the metabolites produced exhibit different anti-inflammatory properties (73) . Similarly, the flavonoid quercetin generated 5 by gut microbial enzymes exerts a higher effect in the down-regulation of the inflammatory responses than the glycosylated form present in vegetables (quercitrin or 3-rhamnosylquercetin) (83) . This effect is exerted by inhibiting cytokine and inducible nitric oxide synthase expression through inhibition of the NF-kappaB pathway both in vitro and in vivo (83) . In contrast, the ellagitanin punicalagin that is the most potent 10 antioxidant found in pomegranate juice is extensively metabolized to hydroxy-6H-dibenzopyran-6-one derivatives, which did not show significant antioxidant activity compared to punicalagin (84) . Therefore, polyphenols appear to have potential to confer health benefits via modulation the gut microecology. However, the effects of interplay between polyphenols and specific gut microbiota functions remain largely uncharacterized. 20
Conclusions and future perspectives
The gut microbiota exerts an enormous impact on the nutritional and health status of the host via modulation of the immune and metabolic functions. The microbiome provides additional enzymatic activities involved in the transformation of dietary 25 compounds. Food bioactive compounds also exert significant effects on the intestinal environment, modulating the gut microbiota composition and probably its functional effects on mammalian tissues. This evidence is changing the way the biological roles of functional food components are being investigated since their metabolites and effects may depend on the gut microbiota and even change from one individual to another. 5
Advances on the knowledge of the interactions between bioactive food compounds and specific intestinal bacteria could contribute to a better understanding of both positive and negative interactions in vivo and to the identification of new functional microorganisms inhabiting our intestinal tract. 
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